CRISPR Therapeutics
CRSP
#2966
Rank
โ‚น371.75 B
Marketcap
โ‚น4,355
Share price
-0.50%
Change (1 day)
-4.35%
Change (1 year)

CRISPR Therapeutics (CRSP) - Cash on Hand

Cash on Hand as of June 2024 : โ‚น40.87 Billion

According to CRISPR Therapeutics's latest financial reports the company has โ‚น40.87 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

CRISPR Therapeutics - Cash on Hand chart (from 2015 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚น140.99 B-6.14%
2022-12-31โ‚น150.21 B-15.17%
2021-12-31โ‚น177.08 B43.25%
2020-12-31โ‚น123.62 B83.68%
2019-12-31โ‚น67.30 B110.78%
2018-12-31โ‚น31.93 B108.57%
2017-12-31โ‚น15.30 B-28.6%
2016-12-31โ‚น21.44 B106.87%
2015-12-31โ‚น10.36 B17205.07%
2014-12-31โ‚น59.89 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚น24.16 B-40.88%๐Ÿ‡บ๐Ÿ‡ธ USA